July 14, 2026 Genomic Integrity: The Fourth Pillar of Quality in Cell and Gene Therapy For decades, the biopharmaceutical industry has relied on three foundational... Read More
April 7, 2026 The Biggest Risk in In Vivo Therapeutic Engineering Is What We Cannot See In vivo therapeutic engineering is often framed as the next logical evolution... Read More
February 17, 2026 The Next Evolution of Cytogenetics: From Observation to Action For decades, cytogenetics has played a critical role in therapy development. It... Read More
September 9, 2025 Navigating the Hidden Risks of CRISPR with the KROMASURE™ Platform A recent Perspective in Nature Communications, “The hidden risks of CRISPR/Cas:... Read More
